Skip to main content
. Author manuscript; available in PMC: 2018 Jan 8.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Mar 21;21(6):1074–1082. doi: 10.1016/j.bbmt.2015.03.014

Figure 2.

Figure 2

Change in chronic GVHD severity. (A) Indicates distribution of NIH global 0 to 3 scores at baseline, 3 months, and 6 months. (B) Indicates change in global NIH 0 to 3 score from baseline to 6 months separately for those with initial score 2 (top) versus 3 (bottom). (C) Indicates clinician-reported overall response category at 3 months (top) and 6 (bottom) months.